how.to.microdose glp 1 Microdose GLP-1 Protocol Starting GLP-1 doesn't always have

Date of last expert review December 2, 2025

General Information The incretin concept arose with the realization that oral glucose induced a greater increase in insulin secretion than did intravenous administration in normal humans (71)

patients receiving ADMs saw noticeable spikes in the rate of discontinuation due to medication availability in January 2023 (5.3%) and June 2024 (4.8%), while patients receiving AOMs experienced higher rates of discontinuation due to medication availability throughout 2023 and into early 2024

Step 2: Choose a Legitimate Platform What a Legitimate Platform Has Licensed independent providers: prescribing done by MDs, DOs, or NPs not the company itself Named pharmacy partner: you can ask which compounding pharmacy they use and get a clear answer Certificate of Analysis available: independent batch testing documentation provided on request HIPAA-compliant infrastructure: dual-database PHI isolation, signed BAAs with all vendors Ongoing monitoring: mandatory monthly provider re-reviews, not just a one-time prescription Full refund if declined: automatic refund if the provider does not approve your intake RED FLAGS AVOID THESE PLATFORMS Be very cautious of platforms that: Cannot name their pharmacy or provide a Certificate of Analysis Claim to offer oral semaglutide compounds Price everything under $100/month all-in without explanation Do not require a licensed provider prescription and consultation Have no ongoing clinical monitoring after the initial prescription Use high-pressure sales tactics to push you toward a specific medication before assessment Step 3: Complete the Medical Intake (10 Minutes) The clinical intake form is the core of your asynchronous consultation

Absence of QTc prolongation in a thorough QT study with subcutaneous liraglutide, a once-daily human GLP-1 analog for treatment of type 2 diabetes

(2014c)